The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of CD4+PD-1+CXCR6+ T cells on the response of immune checkpoint inhibitor therapy in brain metastases of NSCLC.
 
Yang-Si Li
No Relationships to Disclose
 
Wenpu Lai
No Relationships to Disclose
 
Kai Yin
No Relationships to Disclose
 
HaiYan Tu
No Relationships to Disclose
 
Liang Li
No Relationships to Disclose
 
Shou-Heng Lin
No Relationships to Disclose
 
Peng Li
No Relationships to Disclose
 
Jin-Ji Yang
No Relationships to Disclose
 
Qing Zhou
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; MSD; Pfizer; Roche
 
Wen-Zhao Zhong
No Relationships to Disclose
 
Xuchao Zhang
No Relationships to Disclose
 
Xue-Ning Yang
No Relationships to Disclose
 
Lu Zeng
No Relationships to Disclose
 
SiYang Liu
No Relationships to Disclose
 
Yangqiu Li
No Relationships to Disclose
 
Oscar Junhong Luo
No Relationships to Disclose
 
Meimei Zheng
No Relationships to Disclose
 
Yi-Long Wu
Honoraria - AstraZeneca; BeiGene Beijing; Boehringer Ingelheim; Bristol-Myers Squibb/China; Hengrui Pharmaceutical; MSD Oncology; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Roche; Takeda
Research Funding - BMS (Inst); Boehringer Ingelheim (Inst); Pfizer (Inst); Roche (Inst)